TABLE 3.
Group I (The control group) |
Group II (TAA-treated group) |
|
GFAP gene expression (2–ΔΔCT) | 1 ± 0.02 | 1.91 ± 0.16* |
TNF-α gene expression (2–ΔΔCT) | 1 ± 0.02 | 2.12 ± 0.13* |
AQP4 gene expression (2–ΔΔCT) | 1 ± 0.03 | 2.41 ± 0.11* |
Kir4.1 gene expression (2–ΔΔCT) | 1 ± 0.03 | 0.61 ± 0.04* |
*Significant compared to control group.